Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial
Articolo
Data di Pubblicazione:
2007
Citazione:
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial / Olsson, Lg; Swedberg, K; Cleland, Jg; Spark, Pa; Komajda, M; Metra, Marco; Torp Pedersen, C; Remme, Wj; Scherhag, A; Poole Wilson, P; Comet, Investigators. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 9(8):(2007), pp. 795-801.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Olsson, Lg; Swedberg, K; Cleland, Jg; Spark, Pa; Komajda, M; Metra, Marco; Torp Pedersen, C; Remme, Wj; Scherhag, A; Poole Wilson, P; Comet, Investigators
Link alla scheda completa:
Pubblicato in: